With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated. But this is also a good time to reflect on the decades of work that laid the groundwork for this lightning fast vaccine development effort. … READ MORE >
biotech
Biotech needs cash in hesitant market
Life science companies require a cash infusion at least twice as big as that of 2018 to fund research and development at a time when investors remain skittish, according to a Bloomberg analysis. … READ MORE >